Actively Recruiting
HIV Suicide Prevention With AI-DBT
Led by Rutgers, The State University of New Jersey · Updated on 2026-01-15
50
Participants Needed
2
Research Sites
125 weeks
Total Duration
On this page
Sponsors
R
Rutgers, The State University of New Jersey
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.
CONDITIONS
Official Title
HIV Suicide Prevention With AI-DBT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 50 or older
- Evidence of suicide risk as shown by at least one of the following: PHQ-9 suicide item greater than 0, Ask Suicide Questions (ASQ) score above 0, expressed suicidal thoughts to a provider, a suicide attempt in the past year, or PHQ-9 total score of 8 or higher
- Ability to read and communicate fluently in English or Spanish
- Not at imminent risk for suicide (no significant intent to die within 48 hours)
- Has a smartphone capable of texting and accessing the internet
You will not qualify if you...
- Clinically inappropriate to participate due to severe psychosis
- Severe substance use that interferes with comprehension
- Severe cognitive deficits that prevent understanding of study and intervention materials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
New Jersey Community Research Initiative
Newark, New Jersey, United States, 07103
Actively Recruiting
2
RWJB Infectious Disease
Newark, New Jersey, United States, 07112
Not Yet Recruiting
Research Team
J
Jared Khan, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here